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Two strains of simian immunodeficiency viruses (SIV) isolated from chimpanzees (SIVcpz.cAs and SIVCPZOABP) originating 
from Gabon have previously been genetically characterized and shown to belong phylogenetically to the same lineage 
as the human immunodeficiency virus type 1 (HIV-1). We describe the sequence analysis of a third HIV-1-related virus, 
SIVCPZ-ANT, isolated from a wild captured chimpanzee originating from Zaire. This virus displayed the same genetic organiza- 
tion as HIV-1 and was found to fall on the same lineage as HIV-1 and SIVcpzGAB. Protein sequence identity with SIVcPz-oAB 
ranged from 72% (Pol) to 48% (Env) for the structural proteins, while a particularly divergent Vpu was found (only 25% 
identity to SIVCPZ-OAB). The V3 regions of the SIVcPz isolates were exceptionally conserved in contrast to the high divergence 
of V3 among HIV-1 isolates. However, SIVcPz.ANT did not show a greater degree of sequence similarity with SIVCpZCAB than 
with HIV-1 isolates and represents a quite divergent outgroup of the HIV-1 lineage. Our data suggest multiple introductions 
of HIV-1 in the human population and shed new light on the origin of the HIV-1 pandemic. Q 1996 Academic Press. tnc 
Lentiviruses have been isolated from a variety of pri- 
mate species and constitute human immunodeficiency 
virus types 1 and 2 (HIV-1 and HIV-2, which cause AIDS) 
and simian immunodeficiency viruses (SIV) isolated from 
nonhuman primates. Phylogenetic analysis indicates that 
these viruses form five major lineages, with the two hu- 
man viruses falling into different lineages (7, 2). HIV-2 is 
most closely related to SIVsM, isolated from sooty manga- 
beys, and various lines of evidence suggest that HIV-2 
has arisen through cross-species transmission of SIV 
from sooty mangabeys in West Africa (3-5). 
been suggested that most SIV (including viruses from 
chimpanzees, African green monkeys, and sooty manga- 
beys) may have arisen through cross-species transmis- 
sion from humans (70, 7 7). Phylogenetic analyses of re- 
cently isolated HIV-1 variants reveal that there are two 
major lineages, named groups M and O: the two Gabo- 
nese chimpanzee viruses cluster with group M (7) and 
thus within $e HIV-1 radiation. While this relationship 
would indeed seem to be most simply explained by hu- 
man-to-chimpanzee transmission, it has been pointed 
out that cross-species transmission of primate lentivi- 
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TABLE 1 
Amino Acid Sequence Identity (%) between SIVcpz-ANT, SIVCPZ.OAB, and Prototype HIV/SIV Isolates" 
SIVCPZ-ANT 
compared 
withb GAG POL VIF VPR VPU TAT ENV REV NEF 
S ~VCPZ-GAB 65 72 52 62 25 57 48 42 51 
HIVMN (MI 59 71 54 61 17 61 47 37 47 
H~VAN~O (0) 63 ' 70 50 61 19 52 43 57 53 
S~VAGM 52 60 26 - - 34 36 31 43 
S~VMND 51 58 27 48 - 42 31 20 31 
S~VSMM 51 58 32 46 - 39 37 17 41 
SlVSYK 46 54 28 25 - 40 41 34 38 
' Chromosomal DNA was prepared from human lymphocytes infected in vitro with the SIVCPZ.ANT virus isolate. Regions highly conselved between 
HIV-1 and SIVCPZ.GAB were chosen to design oligonucleotides (and nested oligonucleotides) to prime the reactions. In later experiments. reactions 
were primed using oligonucleotides derived from the SIVcpz.ANT sequences themselves. In most cases, the following reaction conditions were used: 
a l-min denaturation step at 95°C. a 2-min annealing step at 37°C or 50T, and 1- to 2-min elongation step at 72°C. For the majority of the regions, 
a PCR consisting of 30 cycles was insufficient and a second PCR of 30 cycles was needed, using a nested primer pair. The resulting amplification 
products were tested upon hybridization with HIV-1 probes under low stringency conditions as described (28). Sequence analysis was performed 
on cloned PCR fragments using the dideoxy chain termination method (29), and the sequence has been deposited in the GenBank/EMBL database 
(accession number U42720). 
* Sequences were aligned using the program Palign (PCgene software package, structure-genetic matrix). The program parameters open gap 
penalty and unit gap penalty were both set at five. For each alignment, the SIVcpz.ANT protein sequence was compared individually to the corresponding 
protein of the following strains SIVCPZ-GnB, HlVMN (representative of group M within the HIV-1 lineage), HIVAN~O (representative of group O within 
- 
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the HW-1 lineage), S~VAGM wo)$ S~VSMM (PBJ), SIVMND (cm, and SIVSYKIKEN). 
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with serological:.data which also indicate that this virus 
belongs to the  HIV-1 family (14). Although w e  d o  not 
know whether  the sequence  described here represents a 
biologically functional clone, virus can  readily b e  isolated 
from t h e  infected animal (75). As within primate lentivi- 
ruses in general, the  proteins encoded by gag and  pol 
are  more conserved than the  envelope o r  regulatory pro- 
teins (Table l). From these  protein sequence  compari- 
sons ,  SIVCpZ-ANT is clearly more similar to SIVCpZ-GAB and 
HIV-1 t han  to representatives of the  other four major 
l ineages but, surprisingly, SIVCpZ-ANT does  not s e e m  to 
b e  more  similar to SIVCPZ-GAB than to HIV-1 isolates. We 
protein is remarkable for two reasons: first, compared to 
SIVCPZ-GAB, four extra cysteine residues a re  present a t  
positions 614, 623, 706, and 788 (Fig. 2A); second, only 
four cysteine residues a re  found a t  equivalent positions 
when both SIV envelope proteins a re  aligned (residues 
591, 597, 776, and 795). The only SIV subtype currently 
known to contain a larger number of cysteine residues 
in its transmembrane protein is SIVAGM, whereas in s o m e  
primary HIV-1 isolates extra cysteine residues have also 
been observed (16). The structural implications resulting 
from t h e s e  changes  are presently unknown. The addi- 
tional cysteine residues in SIVCPZ-ANT might have conse- 
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FIG. 1. Phylogenetic relationship of SIVCPZ.ANT to representative primate lentiviruses. Predicted Gag, Pol, and Env protein sequences were aligned 
and then concatenated: pairwise distances were calculated by Kimura's method (30), and the phylogeny was estimated by the neighbor-joining 
method (37) with 1000 bootstraps: these methods were implemented using CLUSTAL W (32). The tree is midpoint rooted. Horizontal branch lengths 
are 10 scale the bar indicates 10% (0.10 amino acid replacements per site). All clusters within the HIV-l/SIVcpZ lineage were found in 100% of 
bootstraps. The same branching order within the HIV-l/SIVcpZ lineage was found in trees estimated from Gag, Pol, and Env proteins analyzed 
iqdividually and in trees estimated by the maximum parsimony and weighted parsimony methods. 
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FIG. 3. Vpu protein of SIVCP~.AN~. (A) Alignment of Vpu proteins from S l v c p ~ . ~ ~ ~ ,  HIV-1 M, and HIV-1 O isolates using CLUSTAL W. 
Residues identical across all four sequences are indicated by *. The HIV-1 conserved Vpu motif is underlined. (B) Hydropathy profiles of the 
SIVCPZ.ANT (left) and SIVCPz.GAB (right) Vpu proteins were calculated according to Kyte and Doolinle (34). Positive scores are hydrophobic and the 
amino acid number is indicated on the X-axis. 
with their complete envelope proteins. The similarity be- 
tween the two S¡Vcpz sequences does not extend beyond 
the V3 loop and therefore seems unlikely to be due to 
recombination between these W o  lineages. Variation is 
also limited in the V3 sequences of isolates obtained 
from one infected animal as shown in a study of consecu- 
tive isolates obtained from the SIV,pz-ANT-infected chim- 
panzee (15). Noting that, unlike HIV-1, the V3 domain in 
SIVMAc from macaques is not involved in neutralization 
(18), these observations raise the question whether the 
V3 domain in SIVcpz is functionally equivalent to the PND 
of HIV-1. The low degree of variation found in the V3 
not at the same position (Fig. 2). The WDINDL box which 
is located at the C-terminus of the protein has also been 
described as critical for the functioning of Vpu (21). This 
motif is conserved in group M isolates, but not in the 
SIVcpz isolates or in group O strains (2). This 0bse:rvation 
is in keeping with previous data which indicate that pro- 
teins with identical or similar functions and structure do 
not need sharing of extensive sequence similarity (22). 
In conclusion, as part of an ongoing international effort 
to document the genetic variation of SIV and HIV, we 
have studied a new lentivirus, SIVCpZ-ANT, isolated from a 
wild captured chimpanzee. While this virus clearly be- 
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panzees argues against it. The alternative remains that 
both h u m a n s  and chimpanzees have acquired their len- 
tiviruses from an as yet unidentified third species of Afri- 
can primate. In this scenario, there would also have been 
two independent introductions into the chimpanzee pop- 
ulation. The apparent frequency of cross-species trans- 
mission of primate etroviruses (72, 23) suggests that this 
is not unlikely. Exactly when (or where on the phyloge- 
netic tree) these transfers might have occurred remains 
open to question: thus, whether the SIVCPZ-ANT lineage 
might have infected chimpanzees only recently, or at a 
more ancient time near the node connecting that branch 
to others in the phylogeny, must still be resolved. If it is 
assumed that a long-term relationship between a patho- 
gen and its host leads to loss of pathogenicity (24, then 
the apparent lack of an AIDS-like pathology in chimpan- 
zees and the failure of HIV-1 to cause disease in chim- 
panzees (25, 26) could be interpreted a s  an indication 
that SIV infection of this species is not a recent phenome- 
non. However, the recent reports of an AIDS-like pathol- 
ogy occurring in an HIV-l-infected chimpanzee (27) may 
require reconsideration of the latter argument. 
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